Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

In these cases, the major issue is to distinguish FNH-like nodules from hepatocellular carcinoma (HCC ... Von Meyenburg complexes are small, often subcapsular nodules. If the hamartomas are ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...